Literature DB >> 12573534

Hypothermia suppresses inducible nitric oxide synthase and stimulates cyclooxygenase-2 in lipopolysaccharide stimulated BV-2 cells.

Hannah Gibbons1, Timothy A Sato, Mike Dragunow.   

Abstract

Hypothermia is neuroprotective, possibly through suppression of microglial activation. We investigated the effects of hypothermia on lipopolysaccharide (LPS) stimulated BV-2 cells. At 37 degrees C, LPS elicited strong increases in inducible nitric oxide synthase (iNOS), nitric oxide (NO), cyclooxygenase-2 (COX-2), tumour necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6), accompanied by translocation of nuclear factor-kappaB (NF-kappaB) to the nucleus. Hypothermia (33 degrees C) caused complete suppression of iNOS and NO, a partial reduction of IL-6 but did not prevent TNF-alpha production or NF-kappaB translocation. In contrast, LPS induced cyclooxygenase-2 (COX-2) to higher levels under hypothermic conditions. These results show that hypothermia selectively suppresses iNOS in microglia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573534     DOI: 10.1016/s0169-328x(02)00585-5

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  21 in total

1.  Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia.

Authors:  Carla M Webster; Stephen Kelly; Maya A Koike; Valerie Y Chock; Rona G Giffard; Midori A Yenari
Journal:  Neurobiol Dis       Date:  2008-11-19       Impact factor: 5.996

2.  Hypothermia Attenuates Neuronal Damage via Inhibition of Microglial Activation, Including Suppression of Microglial Cytokine Production and Phagocytosis.

Authors:  Tomoka Kimura; Kohki Toriuchi; Hiroki Kakita; Tetsuya Tamura; Satoru Takeshita; Yasumasa Yamada; Mineyoshi Aoyama
Journal:  Cell Mol Neurobiol       Date:  2020-05-07       Impact factor: 5.046

3.  CD200 attenuates methamphetamine-induced microglial activation and dopamine depletion.

Authors:  Xia Yue; Dongfang Qiao; Aifeng Wang; Xiaohui Tan; Yanhong Li; Chao Liu; Huijun Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

4.  Hypothermia at 35 °C reduces the time-dependent microglial production of pro-inflammatory and anti-inflammatory factors that mediate neuronal cell death.

Authors:  Tomohiro Matsui; Yusuke Yoshida; Masashi Yanagihara; Hiromi Suenaga
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

5.  Temperature-related effects of adenosine triphosphate-activated microglia on pro-inflammatory factors.

Authors:  Tomohiro Matsui; Yukari Motoki; Takafumi Inomoto; Daisuke Miura; Yukiko Kato; Hiromi Suenaga; Keisuke Hino; Junzo Nojima
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

6.  Temperature- and time-dependent changes in TLR2-activated microglial NF-κB activity and concentrations of inflammatory and anti-inflammatory factors.

Authors:  Tomohiro Matsui; Moe Tasaki; Takahiro Yoshioka; Yukari Motoki; Hidehiro Tsuneoka; Junzo Nojima
Journal:  Intensive Care Med       Date:  2012-06-01       Impact factor: 17.440

7.  Hypothermia Reduces but Hyperthermia Augments T Cell-Derived Release of Interleukin-17 and Granzyme B that Mediate Neuronal Cell Death.

Authors:  Tomohiro Matsui; Natsumi Kawahara; Arisa Kimoto; Yusuke Yoshida
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

Review 8.  Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Authors:  M M Ning; M Lopez; D Sarracino; J Cao; M Karchin; D McMullin; X Wang; F S Buonanno; E H Lo
Journal:  Neurol Res       Date:  2013-06       Impact factor: 2.448

9.  Therapeutic effects of pharmacologically induced hypothermia against traumatic brain injury in mice.

Authors:  Jin Hwan Lee; Ling Wei; Xiaohuan Gu; Zheng Wei; Thomas A Dix; Shan Ping Yu
Journal:  J Neurotrauma       Date:  2014-07-07       Impact factor: 5.269

10.  iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management.

Authors:  Shi-Xiang Cheng; Zhong-Wei Xu; Tai-Long Yi; Hong-Tao Sun; Cheng Yang; Ze-Qi Yu; Xiao-Sa Yang; Xiao-Han Jin; Yue Tu; Sai Zhang
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.